key: cord-1008787-n1t8l9a9 authors: Husain, Rola; Corcuera-Solano, Idoia; Dayan, Etan; Jacobi, Adam H; Huang, Mingqian title: Rhabdomyolysis as a manifestation of a severe case of COVID-19: A Case Report date: 2020-07-07 journal: Radiol Case Rep DOI: 10.1016/j.radcr.2020.07.003 sha: e93260a8366e46d1406e4b6eb5b704a0a562a583 doc_id: 1008787 cord_uid: n1t8l9a9 Since the outbreak of the ongoing pandemic of the novel coronavirus disease (COVID-19) in Wuhan, China, from December 2019, we have learned that multiple organs can be affected with the potential for various complications. Although myalgia is a frequent symptom in COVID- 19 patients, no imaging findings of rhabdomyolysis have been featured in the literature. We report a case of presumed rhabdomyolysis in a 38-year-old male with COVID-19 based on the clinical presentation, laboratory results and radiological findings. By discussing the diagnostic rationale and reviewing the relevant literature we hope to advance the existing understanding of this disease and its effects on the musculoskeletal system. Rhabdomyolysis has been reported to be associated with COVID-19 [4, 5, 6 ], yet no concomitant CT findings were published. We present a case report of a clinically diagnosed rhabdomyolysis in a young COVID 19 patient, with muscle changes on CT. A 38-year-old male presented to the emergency department of Mount Sinai health system (New York City, NY) with chief complaints of fever, cough, shortness of breath and myalgia on March 22 nd , 2020. Potential risk factors include a BMI of 29.9 and history of a daily vaping. There was no history of recent travel or known contact with COVID-19 positive individuals. The patient underwent a CT angiogram to evaluate possible pulmonary embolism in the emergency department. There was no pulmonary embolism, however, bilateral numerous multifocal ground glass opacities were deemed compatible with multifocal viral pneumonia [ Figure 1 ]. Based on CT findings, a SARS COV2 PCR nasopharyngeal swab test was conducted and confirmed that the patient was COVID-19 positive. He was placed on droplet precautions and contact isolation. Blood and sputum culture, urine/sputum legionella testing and mycoplasma IGM tests were performed, with negative results. On admission, he was placed on subcutaneous Heparin (5000 units, every 12 hours) as his Ddimer was elevated (0.64) [Normal values <0.50], to be adjusted later during his hospital course due to multiple occurring events. The patient decompensated, was intubated for acute hypoxemic respiratory failure and admitted to the intensive care unit over the course of five days since admission and was placed on Plaquenil (400 mg), supplemental oxygen, albuterol sulfate and tiotropium bromide and Three months post admission, with ongoing interdisciplinary rehabilitation therapy program; the patient is starting to recover with discharge arrangements being made. Rhabdomyolysis is a life-threatening syndrome resulting from striated muscular breakdown, which may occur due to various factors, including metabolic, trauma, inflammatory, infectious, ischemic, and autoimmune conditions, as well as complications of drug therapy [7] . Viral infections, such as influenza A/B (most commonly), Epstein-Barr, herpes simplex, adenovirus, human immunodeficiency virus and cytomegalovirus have all been found to cause rhabdomyolysis. Patients usually present with myalgia, fatigue, and, in some cases, acute renal failure [4, 6] . As COVID-19 is known to incite an immune reaction in individuals, it remains unclear whether these changes are attributed to direct viral induced muscular damage or a secondary autoimmune reaction [4] . In our case, we reached the conclusion of rhabdomyolysis, secondary to COVID-19 based on the following three points: 1-The patient's complaint of worsening muscular pain and weakness [4, 5, 6] with concomitant imaging findings of bilateral symmetrical shoulder and posterior thoracic muscle calcification that progressed in attenuation and extent on serial CT scans [8] . 2-Progressive elevation of creatinine kinase, reaching (33, 000 mcg/L), the developing hypocalcemia, and the refractory hyperkalemia (out of proportion with the degree of renal function) were all in favor of rhabdomyolysis [7] . 3-Significantly elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels [9] . Although myositis was considered, the presence of intramuscular calcification rather than low attenuation (muscle edema) and lab results favored of rhabdomyolysis [10] . With regards to radiological features in rhabdomyolysis, CT changes of rhabdomyolysis are reportedly more variable, as affected areas either appear hyperdense from calcification, or hypodense due to muscle edema [11, 12] . The calcification seen within the muscles occurs either due to calcium sequestration, coinciding with reduced serum calcium (as in our case) and development of acute renal failure or as a result of administration of calcium to correct a hypocalcaemia [11] . There is feathery, streaky enhancement of affected muscles following intravenous contrast [12] . On MRI, acute and subacute rhabdomyolysis has been reported to exhibit iso to high signal intensity on T1weighted images and high signal intensity on T2 weighted images with contrast enhancement. T1 signal changes reflect the presence of methemogloin, proteinaceous materials and fat, whereas T2 changes reflect accumulated water from myonecrosis. In chronic rhabdomyolysis, low signal intensity on T2 weighted images is attributed to the accumulated hemosiderin [11] . Two types of rhabdomyolysis have been described; type one is related to edema and the concomitant CT and MRI changes include homogenous density and signal intensity, on all sequences, respectively, in addition to the exhibition of a homogenous enhancement. While, type two is thought to result from myonecrosis, thus the related radiological changes are deemed heterogeneous in density, signal intensity and contrast enhancement [12. 13] . A specific sign has been described on both CT and MRI images of rhabdomyolysis (stipple sign) which appears as an enhanced central dot or linear focus surrounded by an area of rim enhancement, which was found to be specific for type two rhabdomyolysis [12, 13] . Although, MRI and nuclear medicine scan [technetium-99m medronate or pyrophosphate] [12] have the highest sensitivity for detecting rhabdomyolysis in acute setting, CT has kept its superiority in its ability of detecting calcification with fast scanning compared to the above modalities [8] . Ultrasound use has been encouraged as well, as it shows decreased echogenicity within the involved muscles [14] . Other advantages of ultrasound include the low cost and lack of ionizing radiation. Although muscle biopsy can be used to confirm the diagnosis, it has been discouraged (and was not performed in this case) due to the risk of multiple complications, including bleeding and prolonged recovery [11, 15] . Some authors argue that it is unnecessary as the histopathological findings do not usually reveal the etiology [16] . Although our case is limited by the lack of histopathology results, and the confirmation of the main etiology (as it can be related to the SARS-CoV-2 virus or the provoked immune reaction), we have reached our diagnosis by combining the clinical history of muscular pain and weakness, elevated creatinine kinase levels and imaging findings [4, 7, 11] . COVID-19 infection has many manifestations that are not solely limited to the respiratory system. We present a case of a presumed rhabdomyolysis in a COVID-19 positive patient with a complicated clinical course, in hope to shed more light on this multifaceted disease and draw the attention of radiologists and other clinicians in the frontline to this entity that can take a devastating turn on patients' prognosis. Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors. Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney international Cutaneous manifestations in COVID-19: a first perspective Rhabdomyolysis as a presentation of 2019 novel coronavirus disease Rhabdomyolysis as potential late complication associated with 2019 novel coronavirus disease. Emerg Infect Dis Rhabdomyolysis associated with probable SARS. The American journal of medicine Internal and emergency medicine CT of rhabdomyolysis associated with malignant hyperthermia and seizures. Clinical imaging Liver aminotransferases are elevated with rhabdomyolysis in the absence of significant liver injury Myositis as a manifestation of SARS-CoV-2. Annals of the Rheumatic Diseases Rhabdomyolysis: magnetic resonance imaging and computed tomography findings Rhabdomyolysis: computed tomography findings Rhabdomyolysis of the head and neck: computed tomography and magnetic resonance imaging findings. Dentomaxillofacial Radiology Ultrasonic appearance of rhabdomyolysis Sonography of diabetic muscle infarction with MR imaging, CT, and pathologic correlation Rhabdomyolysis: a review of the literature Patient consent for publication Not required.